The efficacy of different immunotherapy strategies to NSCLC patients after resistance to EGFR-TKIs: A retrospective study

被引：0
|
作者：
Huang, Jiuyan [1 ]
Wei, Chunhua [1 ]
Wang, Huijuan [1 ,2 ]
机构：
[1] Zhengzhou Univ, Dept Med Oncol, Affiliated Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China
[2] Henan Canc Hosp, 127 Dongming Rd, Zhengzhou 450008, Henan, Peoples R China
来源：
ASIAN JOURNAL OF SURGERY | 2024年 / 47卷 / 11期
关键词：
Advanced NSCLC; Immunotherapy; EGFR-TKIs resistance;
D O I：
10.1016/j.asjsur.2024.05.257
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：5078 / 5079
页数：2
相关论文
共 50 条
  • [31] Dynamics of EGFR mutations in plasma recapitulates the clinical response to EGFR-TKIs in NSCLC patients
    Xiong, Liwen
    Cui, Shaohua
    Ding, Jingyan
    Sun, Yun
    Zhang, Longfu
    Zhao, Yizhuo
    Gu, Aiqin
    Chu, Tianqing
    Wang, Huimin
    Zhong, Hua
    Ye, Xin
    Gu, Yi
    Zhang, Xin
    Hu, Min
    Jiang, Liyan
    ONCOTARGET, 2017, 8 (38) : 63846 - 63856
  • [32] EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with multiple brain metastases
    Jiang, T.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2019, 30
  • [33] EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases
    Jiang, Tao
    Zhang, Yongchang
    Li, Xuefei
    Zhao, Chao
    Chen, Xiaoxia
    Su, Chunxia
    Ren, Shengxiang
    Yang, Nong
    Zhou, Caicun
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 98 - 108
  • [34] An EGFR KDD Data in the Chinese NSCLC Population and the Response to EGFR-TKIs: A Multicenter Study
    Wang, W.
    Xu, C.
    Zhu, Y.
    Fang, M.
    Zhuang, W.
    Chen, Y.
    Chen, G.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (12) : S1081 - S1081
  • [35] Clinical efficacy and safety of apatinib combined with EGFR-TKIs in advanced non-small cell lung cancer with EGFR-TKIs resistance
    Tian, Ruifen
    Guo, Yi
    Zhang, Xia
    Zhang, Xing
    Guo, Wei
    Zhu, Haibo
    Xu, Junjun
    Shen, Fangfang
    Song, Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Monitoring acquired resistance to EGFR-TKIs and clonal evolution in metastatic NSCLC patients using liquid biopsies
    Knebel, Franciele
    Bettoni, Fabiana
    Shimada, Andrea
    Cruz, Manoel
    Alessi, Joao Victor
    Negrao, Marcelo
    Muniz, David
    Reis, Luiz Fernando
    Katz, Artur
    Feher, Olavo
    Saragiotto, Daniel
    Camargo, Anamaria
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [37] Rare and Common EGFR Mutations in Patients with Advanced NSCLC Treated with EGFR-TKIs: A Registry-Based Study
    Pesek, Milos
    Kolek, Vitezslav
    Skrickova, Jana
    Cernovska, Marketa
    Koubkova, Leona
    Roubec, Jaromir
    Salajka, Frantisek
    Zemanova, Milada
    Krejci, Jana
    Hejduk, Karel
    Ryska, Ales
    Minarik, Marek
    Fiala, Ondrej
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [38] Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation
    Daoan Cheng
    Banglu Wang
    Lige Wu
    Rui Chen
    Weiqing Zhao
    Cheng Fang
    Mei Ji
    Medical Oncology, 40
  • [39] Efficacy of Aumolertinib in EGFR T790M-negative or -unknown NSCLC with Brain Metastases Following Resistance to Prior EGFR-TKIs
    Han, C. B.
    Dai, Z. X.
    Jin, B.
    Cui, W.
    Man, L.
    Zhang, H. J.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S341 - S341
  • [40] Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation
    Cheng, Daoan
    Wang, Banglu
    Wu, Lige
    Chen, Rui
    Zhao, Weiqing
    Fang, Cheng
    Ji, Mei
    MEDICAL ONCOLOGY, 2023, 40 (09)
12345